Biotechnology leader Biocon is fully integrating Biocon Biologics, valuing it at $5.5 billion. The merger involves share ...
WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...
Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.
New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...
The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
The same technology used in COVID-19 vaccines could help prevent muscle damage from snakebites, according to a study ...
Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...
Medical and legal authorities spoke about the ethics and future of biotechnology at a Friday panel hosted by the Program on Science, Technology, and Society at the Harvard Kennedy School. As part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback